Home > Boards > US Listed > Biotechs > Acadia Pharmaceuticals Inc. (ACAD)

Folks, good evening, hope people are adding to

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
harry crumb Member Profile
 
Followed By 185
Posts 10,516
Boards Moderated 0
Alias Born 03/15/13
160x600 placeholder
Acadia Pharmaceuticals and Stoke Therapeutics Announce Collaboration to Pursue Multiple RNA-based Treatments for Severe and Rare Genetic Neurodevelopmental Diseases Business Wire - 1/10/2022 7:00:00 AM
ACADIA Pharmaceuticals (ACAD) Gets a Buy Rating from Leerink Partners TipRanks - 12/22/2021 11:35:35 AM
Acadia Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022 Business Wire - 12/22/2021 9:00:00 AM
Why did Acadia Pharmaceuticals stock dive today? Plans for NUPLAZID label expansion Seeking Alpha - 12/21/2021 4:27:21 PM
ACADIA price target raised at Citi; says cautiously optimistic on plans for NUPLAZID Seeking Alpha - 12/21/2021 11:42:41 AM
Berenberg Bank Sticks to Its Hold Rating for ACADIA Pharmaceuticals (ACAD) TipRanks - 12/21/2021 6:05:17 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 12/20/2021 6:01:06 PM
Acadia Pharmaceuticals Rise 16% on Resubmission Plan for Pimavanserin Dow Jones News - 12/20/2021 5:03:00 PM
Acadia announces resubmission plans for NUPLAZID label expansion Seeking Alpha - 12/20/2021 4:56:34 PM
Acadia Pharmaceuticals Announces Plan for a Resubmission of its Supplemental New Drug Application to U.S. FDA for NUPLAZID® (pimavanserin) Business Wire - 12/20/2021 4:05:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/14/2021 4:52:43 PM
Acadia Pharmaceuticals promotes Mark Schneyer to EVP CFO Seeking Alpha - 12/14/2021 9:23:00 AM
Acadia Pharmaceuticals Announces Promotion of Mark Schneyer to Executive Vice President, Chief Financial Officer Business Wire - 12/14/2021 9:00:00 AM
Acadia Pharma extends gains as Wall Street welcomes trial data in Rett syndrome Seeking Alpha - 12/7/2021 8:13:51 AM
Acadia Rises 21.8% on Positive Lavender Study Results TipRanks - 12/7/2021 6:14:42 AM
Needham Keeps a Hold Rating on ACADIA Pharmaceuticals (ACAD) TipRanks - 12/7/2021 5:54:24 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/6/2021 5:16:53 PM
Acadia says late-stage trial for trofinetide met main goals in Rett syndrome Seeking Alpha - 12/6/2021 4:22:48 PM
Acadia Pharmaceuticals Announces Positive Top-line Results from the Pivotal Phase 3 Lavender Trial of Trofinetide in Rett Syndrome Business Wire - 12/6/2021 4:05:00 PM
The Lancet Psychiatry Publishes Results from ADVANCE Study Evaluating Pimavanserin Treatment for Negative Symptoms of Schizophrenia Business Wire - 12/1/2021 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/23/2021 6:07:45 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/19/2021 6:37:12 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/19/2021 6:36:27 PM
Acadia Pharmaceuticals and StoryCorps Collaborate to Launch Yours, Truly – a Multicultural Storytelling Campaign to Bring Greater Awareness to Parkinson’s Disease Non-Motor Symptoms Business Wire - 11/16/2021 9:00:00 AM
ACADIA Pharma at a three-month high ahead of key update on dementia therapy Seeking Alpha - 11/9/2021 2:47:35 PM
harry crumb   Tuesday, 08/10/21 10:33:02 PM
Re: None
Post # of 3068 
Folks, good evening, hope people are adding to make wealth again here. $$$$$

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences